Log in to search using one of your social media accounts:

 

Genetic Test Criteria Often Miss Breast Cancer Risk
(MedPage Today) -- Similar cancer-linked mutations in patients who did or did not met test criteria (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2018 Category: Hematology Source Type: news

Sunglasses aren't just a fashion statement - they could save your sight!
In the UK, skin cancer rates are rising, with a significant proportion of them being cancers of the eyelid. Here's how to protect yourself - and your sight. (Source: the Mail online | Health)
Source: the Mail online | Health - May 7, 2018 Category: Consumer Health News Source Type: news

How Felix White is helping other children battle the cruel disease that took him away, aged six
When Felix White, from Brighton, was diagnosed with aggressive cancer, aged 4, his life - and death - became a game-changer. This is his incredible story. (Source: the Mail online | Health)
Source: the Mail online | Health - May 7, 2018 Category: Consumer Health News Source Type: news

Dr. Peter Emanuel Resigns from UAMS’ Rockefeller Cancer Institute
The resignation, effective July 31, is the latest high-profile departure in a turbulent year for the University of Arkansas for Medical Sciences. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - May 7, 2018 Category: American Health Source Type: news

Cancerous melanomas can seem like they're only skin deep
Melanoma is one of the most common cancers in the U.S. (Source: ABC News: Health)
Source: ABC News: Health - May 7, 2018 Category: Consumer Health News Tags: Health Source Type: news

HIV Patients to See Shift in Cancer Trends by 2030
(MedPage Today) -- Model predicts decline AIDS-defining cancers; uptick in lung, prostate cancers (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2018 Category: Hematology Source Type: news

The Fukushima legacy: More than just cancer, diabetes diagnoses have increased six-fold
(Natural News) It’s not a secret that nuclear radiation is dangerous: Not only does it cause cancer, even seemingly small amounts of the stuff can be lethal. Exposure to high enough levels can be deadly in frighteningly short periods of time. But for the survivors of the Fukushima disaster, and those living in surrounding areas,... (Source: NaturalNews.com)
Source: NaturalNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

Olympus inks co-development deal with Ai4gi for AI-supported colonoscopy solution
Olympus (TYO:7733) said today it inked a co-development deal with artificial intelligence joint venture Ai4gi which will give Olympus exclusive rights to offer Ai4gi’s AI solution designed for clinical decision support during colonoscopy screening and surveillance procedures. Ai4gi is a joint venture between Imagia and Satis Operations, Tokyo-based Olympus said. The company added that the co-development agreement is intended to improve clinical outcomes during colonoscopy procedures, reduce costs and improve quality of life for patients. “Ai4gi’s solutions to early colon cancer recognition are going ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Software / IT ai4gi Olympus Source Type: news

Varian acquires Taiwanese distributor Cooperative CL Enterprises
Varian Medical (NYSE:VAR) said today it acquired Taiwanese radiotherapy equipment distributor Cooperative CL Enterprises for an undisclosed amount. The distribution company, based in Taipei, currently employs approximately 45 individuals and has represented and distributed Varian equipment for more than 40 years, the Palo Alto, Calif.-based company said. “With the acquisition of COOP, Varian will be able to work and collaborate more closely with our customers in Taiwan as well as providing more efficient and comprehensive services,” Varian Asia Pacific prez Kevin O’Reilly said in a pre...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Mergers & Acquisitions Varian Medical Systems Source Type: news

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC
(MedPage Today) -- First such study in this group; findings run counter to prior research in other cancers (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 7, 2018 Category: Psychiatry Source Type: news

CD40-Activating Monoclonal Antibodies Boost Response to Immunotherapy
Activating CD40 is “a key to initiating a T-cell response to tumors,” says Dr. Robert Vonderheide, MD, director of U Penn’s Abramson Cancer Center. (Source: CancerNetwork)
Source: CancerNetwork - May 7, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Immuno Oncology News Source Type: news

Cancer Incidences and Burden Expected to Shift in HIV-Positive
MONDAY, May 7, 2018 -- The cancer burden among persons living with HIV (PLWH) is projected to shift by 2030, according to a study published online May 8 in the Annals of Internal Medicine. Meredith S. Shiels, Ph.D., from the National Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Drug Combo for Aggressive Thyroid Cancer
MONDAY, May 7, 2018 -- Two anti-cancer drugs administered together have been approved by the U.S. Food and Drug Administration to treat BRAF-positive anaplastic thyroid cancer. Tafinlar (dabrafenib) and Mekinist (trametinib) combined have been... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Does HPV vaccination prevent the development of cervical cancer? Are there harms associated with being vaccinated?
New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials.Most people who have sexual contact at some point in their life will be exposed to the human papilloma virus (HPV). In the majority of women, HPV infection will be cleared by the immune system. When the immune system does not clear the virus, persistent HPV infection can cause abnormal cervical cells. These lesion...
Source: Cochrane News and Events - May 7, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Impact of mass breast cancer screening has been overrated | Letter
It has not been shown to affect women ’s life expectancy overall, but does increase invasive interventions, saySusan Bewley, Nick RossandMargaret McCartney of HealthWatchThe announcement that thousands missed out on mammography tests caused distress to many women and their families (Report, 4 May). The implication was that they now risked premature death from cancer. In fact, as many experts have been pointing out, mass screening for breast cancer has not been shown to have any impact on women ’s life expectancy overall – but it does increase invasive interventions like mastectomy. This is why Prof Mike B...
Source: Guardian Unlimited Science - May 7, 2018 Category: Science Authors: Letters Tags: Breast cancer Health Society Cancer research Medical research Science Women Life and style UK news Jeremy Hunt Politics Source Type: news

Embrace Mediterranean or Nordic diets to cut disease, WHO says
Major study suggests Britain could lower its rates of cancer, diabetes and cardiovascular disease by promoting the dietsBritain could lower its rates of cancer, diabetes and cardiovascular disease by embracing Mediterranean- or Nordic-style diets, a major study into the benefits of healthy eating suggests.A review by the World Health Organization found compelling evidence that both diets reduce the risk of the common diseases, but noted that only 15 out of 53 countries in its European region had measures in place to promote the diets.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 7, 2018 Category: Science Authors: Ian Sample Science editor Tags: Science Health Diets and dieting Society Life and style Food & drink Obesity Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
Odds of poor prognosis after mammography with negative results higher for younger women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Journal, Source Type: news

Parenting Fears Harm Well - Being of Women With Metastatic Cancer
Findings based on survey of women with advanced cancer and dependent children (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 7, 2018 Category: Psychiatry Tags: Gynecology, Nursing, Oncology, Psychiatry, Journal, Source Type: news

Blue Earth expands PSMA-PET/CT imaging portfolio
Molecular imaging firm Blue Earth Diagnostics has signed an agreement for exclusive...Read more on AuntMinnie.comRelated Reading: Blue Earth touts addition of Axumin to NCCN guidelines Blue Earth highlights Axumin clinical results at ASTRO Blue Earth touts Axumin reader training results Blue Earth, PETNet expand Axumin distribution Blue Earth PET radiotracer IDs prostate cancer recurrence (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

Generic Drugs Don't Always Push Prices Down
MONDAY, May 7, 2018 -- Generic drugs tend to trigger big drops in the cost of their expensive, brand-name counterparts, but that has not been the case with the cancer drug commonly known as Gleevec (imatinib). There's been only a small drop in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 7, 2018 Category: General Medicine Source Type: news

Durham pharma eyes potential approval of drug in roughly $5B market
RedHill Biopharma (Nasdaq: RDHL) – which continued to grow its U.S. commercial operations based in Raleigh over the course of 2017 – has its sights set on potential approval of a drug in a market worth roughly $5 billion.  RedHill expects to compete enrollment of close to 450 patients in an ongoing Phase III study for its dru g candidate TALICIA for the treatment of H. pylori infection – which can cause chronic gastritis, ulcers and gastric cancer – in the third quarter of this year. As… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Pamela Laszewski wins Nightingale Award for Nursing Excellence
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - May 7, 2018 Category: Cancer & Oncology Source Type: news

Melanoma Monday: Protecting your family from skin cancer
Dermatologist Dr. Elizabeth Hale discusses the risks for melanoma and the right way to apply sunscreen (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

Study: Open-Label Placebos Relieve Fatigue in Cancer Patients
It is common for cancer patients to experience fatigue during and after cancer treatment. Fatigue usually lessens as patients recover, but some patients experience long-term fatigue that gets in the way of the things they want to do. Mesothelioma survivors are among the many cancer patients who cope with fatigue once treatment ends. New research conducted by scientists at the University of Alabama at Birmingham and Harvard Medical School shows cancer-related fatigue can be relieved by a placebo pill. This relief even occurs when patients are aware they are taking a placebo, known as open-label placebo. A placebo is anythin...
Source: Asbestos and Mesothelioma News - May 7, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Quincy Mother Shares Skin Cancer Survival Story For Melanoma Monday
QUINCY (CBS) – On this Melanoma Monday dermatologists want to bring attention to skin cancer, the most common cancer in the United States. Melanoma is the deadliest form but doctors say it is preventable and treatable if caught early. Katie Michaud, a young mother in Quincy, is well aware of that now. Michaud is grateful she can spend quality time with her two young children because not long ago, her future was uncertain. “I saw my life flash before my eyes,” Katie told WBZ-TV. Katie Michaud. (WBZ-TV) Six months ago, she was about to welcome her second child when a trip to the dermatologist to c...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 7, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Dr. Mallika Marshall Katie Michaud Local TV Melanoma Skin Cancer Source Type: news

UCSF strike begins, disrupting surgeries, cancer care and other treatments
More than 10,000 UCSF employees began a three-day strike today, requiring the medical center ’s hospitals to reschedule surgeries as well as cancer care and other life-saving treatments. The strike will be felt throughout the entire UC system, but in San Francisco the disruptions will hit at UCSF Health, Zuckerberg San Francisco General Hospital and Trauma Center and the UCSF Dental Cent er. UCSF is San Francisco’s second largest employer, after the city itself, with 25,000 employees. That dwarfs… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Emily Fancher Source Type: news

UB spinout working on cancer therapy takes important step toward clinical trials
For-Robin was founded by Kate Rittenhouse-Olson in 2012. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Dan Miner Source Type: news

How to minimize your risk of melanoma
It's Skin Cancer Awareness Month and today is "Melanoma Monday." One in five people will develop skin cancer by age 70. Melanoma is the most dangerous form of skin cancer. Dr. Elizabeth Hale, associate professor of dermatology at NYU Langone Medical Center, joins "CBS This Morning" to offer advice on how to minimize your risk factors. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

Genprex Announces $10 Million Private Placement
AUSTIN, Texas, May 7, 2018 -- (Healthcare Sales & Marketing Network) -- Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today th... Biopharmaceuticals, Oncology, Venture Capital Genprex, Oncoprex, immunogene therapy, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 7, 2018 Category: Pharmaceuticals Source Type: news

Lung cancer warning - this is why you should never ignore chest pain
CANCER symptoms vary depending on which part of the body is affected by a tumour. But, you should never ignore chest pain, as it could be a sign of deadly lung cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - May 7, 2018 Category: Consumer Health News Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
MONDAY, May 7, 2018 -- The likelihood of having breast cancer with a poor prognosis is increased for cancer diagnosed after a screening mammography with negative results, according to a research letter published online May 3 in JAMA Oncology. Anne... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Parenting Fears Harm Well-Being of Women With Metastatic Cancer
MONDAY, May 7, 2018 -- Among women with metastatic cancer and dependent children, parenting concerns negatively impact health-related quality of life (HRQOL), according to a study published online May 7 in Cancer. Eliza M. Park, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Meet Yvette Tremonti, a 2018 CFO of the Year honoree
Name:  Yvette Tremonti Title: Chief financial officer Company: Moffitt Cancer Center Years with company: 22 Category: Government and nonprofit We asked our CFO of the Year honorees a series of non-business questions, since all work and no play makes CFOs a dull group. What do you collect, if an ything? I don’t collect anything. Your first car: Toyota Celica Your walk-up music at The Trop: "The Climb" – Miley Cyrus Who plays you in the movie? Diane Lane Favorite restaurant in the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 7, 2018 Category: Pharmaceuticals Authors: Chris Erickson Source Type: news

Chemical octopus catches sneaky cancer clues, trace glycoproteins
Cancer drops sparse chemical hints of its presence early on, but unfortunately, many of them are in a class of biochemicals that could not be detected thoroughly, until now. Researchers at the Georgia Institute of Technology have engineered a chemical trap that exhaustively catches what are called glycoproteins, including minuscule traces that have previously escaped detection. (Source: World Pharma News)
Source: World Pharma News - May 7, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Groundbreaking workers' compensation case makes link between benzene and cancer
Mitch LaPrade had an 11-year battle to prove that his cancer is linked to contact with the chemical benzene at the printing company where he worked. But firefighters with the exact same form of leukemia are given automatic acknowledgement that benzene exposure on the job is to blame. (Source: CBC | Health)
Source: CBC | Health - May 7, 2018 Category: Consumer Health News Tags: News/Canada Source Type: news

Ask How Aggressive Is Melanoma Cancer
How Aggressive Is Melanoma Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 7, 2018 Category: General Medicine Source Type: news

Ask Is Melanoma Cancer Hereditary
Is Melanoma Cancer Hereditary? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 7, 2018 Category: General Medicine Source Type: news

Drug Duo Approved for Aggressive Thyroid Cancer
Title: Drug Duo Approved for Aggressive Thyroid CancerCategory: Health NewsCreated: 5/4/2018 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 7, 2018 Category: Cancer & Oncology Source Type: news

High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: Study
Title: High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: StudyCategory: Health NewsCreated: 5/4/2018 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 7, 2018 Category: Cancer & Oncology Source Type: news

Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies
DALLAS (May 7, 2018) — Texas Oncology, a practice in The US Oncology Network (The Network), received a 2018 Excellence Award from Pharmacy Benefit Management Institute® (PBMI) for its Medically Integrated Pharmacy Management (MIPM) approach to achieve better results in cancer care. The MIPM model in... (Source: McKesson News)
Source: McKesson News - May 7, 2018 Category: Information Technology Source Type: news

Novel PET tracer could help assess arthritis
Researchers from South Korea have developed a novel PET tracer that can be...Read more on AuntMinnie.comRelated Reading: PET imaging could help personalize cancer treatment PET tracer could better assess lung ailments PET tracks Zika virus, disease progression in mice Novel PET agent could sniff out neurological disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

ASBrS: Regular mammo screening = less-invasive treatment
Regular breast cancer screening, particularly in younger women, translates...Read more on AuntMinnie.comRelated Reading: ASBrS: No, we're not overtreating DCIS ASBrS: 50% of women under 45 at elevated breast cancer risk ASBrS: For node-positive breast cancer, radiotherapy is best ASBrS: Radiotherapy after mastectomy may not be beneficial ASBrS: RF ablation shows promise; thermography not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

Medical News Today: Experimental drug targets prostate cancer's chief weakness
In prostate cancer, recurring tumors become aggressive and treatment-resistant. Why does this happen, and how can it be prevented? A new study weighs in. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 7, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Roche's Tecentriq combo wins fast FDA review in race to catch rivals
ZURICH (Reuters) - Roche's immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get an accelerated review by U.S. regulators for use as an initial treatment of a common form of lung cancer, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche's Tecentriq combination to get speedy FDA review
ZURICH (Reuters) - Roche's immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get a speeded-up review by U.S. regulators for use in initial treatment of people with a common form of lung cancer, the Swiss drugmaker said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination with Avastin® (bevacizumab), paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Vigorous exercise reduces tiredness in testicular cancer survivors
(Cancer Research UK) High-intensity interval training reduces tiredness and improves self-esteem for testicular cancer survivors, according to a study published in the British Journal of Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

By 2030, prostate and lung cancers expected to be most common cancers among HIV population
(American College of Physicians) Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers among individuals aging with HIV. The findings are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news